Shire considers takeover of Swiss biotech group Actelion: Sunday Times

LONDON (Reuters) – Pharmaceutical company Shire is considering a 12 billion pound ($18.32 billion) takeover of Actelion Ltd Europe’s biggest biotech firm, Britain’s Sunday Times newspaper reported, citing unnamed sources.

Source: Business

Leave a Reply

Your email address will not be published. Required fields are marked *

five × 3 =